Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yu...
The collaboration comes after Novo Nordisk terminated a frosty Hims & Hers partn...
Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and ...
The evolving landscape of vaccine oversight makes it key to maintain public trus...
The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) a...
The London Biotechnology Show 2025, held from 18 to 19 June, encompassed a range...
International vaccine group Gavi raised over $9bn, short of an $11.9bn target it...
The US FDA has granted approval for a label update to Eli Lilly and Company's Am...
Drug discovery has traditionally been slow, expensive and prone to failure, but ...
Novartis has completed its previously announced acquisition of Regulus Therapeut...
Kymera’s programme focuses on removing CDK2 from cells compared to other therapi...
Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the devel...
Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, lea...
The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deru...
The FDA's new genAI-assisted scientific review technology, named Elsa, was offic...
